JP2009531036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531036A5 JP2009531036A5 JP2009501824A JP2009501824A JP2009531036A5 JP 2009531036 A5 JP2009531036 A5 JP 2009531036A5 JP 2009501824 A JP2009501824 A JP 2009501824A JP 2009501824 A JP2009501824 A JP 2009501824A JP 2009531036 A5 JP2009531036 A5 JP 2009531036A5
- Authority
- JP
- Japan
- Prior art keywords
- vegf receptor
- domain
- kdr
- receptor fusion
- flt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100662572A CN100502945C (zh) | 2006-03-31 | 2006-03-31 | Vegf受体融合蛋白在治疗眼睛疾病中的应用 |
| PCT/CN2007/001021 WO2007112675A1 (fr) | 2006-03-31 | 2007-03-29 | Protéine de fusion du récepteur du vegf et son utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009531036A JP2009531036A (ja) | 2009-09-03 |
| JP2009531036A5 true JP2009531036A5 (https=) | 2009-12-17 |
Family
ID=37736587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501824A Pending JP2009531036A (ja) | 2006-03-31 | 2007-03-29 | Ｖｅｇｆ受容体融合タンパク質およびそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090264358A1 (https=) |
| EP (1) | EP2000483A4 (https=) |
| JP (1) | JP2009531036A (https=) |
| KR (1) | KR20090010030A (https=) |
| CN (1) | CN100502945C (https=) |
| AU (1) | AU2007234272A1 (https=) |
| BR (1) | BRPI0710223A2 (https=) |
| CA (1) | CA2647142A1 (https=) |
| RU (1) | RU2008136655A (https=) |
| WO (1) | WO2007112675A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2633574T3 (es) | 2005-03-25 | 2017-09-22 | Regeneron Pharmaceuticals, Inc. | Formulaciones de antagonistas de VEGF |
| CA2654510C (en) | 2006-06-16 | 2015-03-17 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
| CN101279092B (zh) * | 2007-04-02 | 2010-10-27 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备治疗与血管生成有关的疾病中的应用 |
| CN101721699B (zh) * | 2008-10-13 | 2012-11-07 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备治疗伴随vegf升高的炎症反应的药物中的应用 |
| KR101248912B1 (ko) * | 2009-12-31 | 2013-03-29 | 한양대학교 산학협력단 | 항혈관신생 활성을 가지는 재조합 아데노바이러스 |
| CN102233132B (zh) * | 2010-04-28 | 2013-10-23 | 成都康弘生物科技有限公司 | Vegf受体融合蛋白在制备抑制眼表新生血管生长的药物中的应用 |
| CN103816115B (zh) * | 2010-08-31 | 2017-06-27 | 成都康弘生物科技有限公司 | 一种含有抑制血管增生的融合蛋白的药物组合物及用途 |
| CN102380096B (zh) * | 2010-08-31 | 2014-04-30 | 成都康弘生物科技有限公司 | 一种含有抑制血管增生的融合蛋白的药物组合物及用途 |
| KR20190049934A (ko) | 2011-01-13 | 2019-05-09 | 리제너론 파아마슈티컬스, 인크. | 혈관신생 눈 장애를 치료하기 위한 vegf 길항제의 용도 |
| KR102049990B1 (ko) | 2013-03-28 | 2019-12-03 | 삼성전자주식회사 | c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질 |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| JP6631865B2 (ja) * | 2014-08-11 | 2020-01-15 | 日本化薬株式会社 | ＴＧＦβ阻害機能を持つキメラタンパク質 |
| CN114306575A (zh) | 2014-12-11 | 2022-04-12 | 拜耳医药保健有限责任公司 | 具有小的活动性脉络膜新生血管病变的年龄相关性黄斑变性的治疗 |
| WO2017046140A1 (en) | 2015-09-18 | 2017-03-23 | Bayer Pharma Aktiengesellschaft | Treatment regimens for dr and rvo in dependence of the extent of retinal ischemia |
| HUE059827T2 (hu) | 2017-11-30 | 2023-01-28 | Regeneron Pharma | VEGF-antagonista alkalmazása angiogén szembetegségek kezelésére |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| DK4364724T3 (da) | 2018-05-10 | 2025-12-22 | Regeneron Pharma | Formuleringer med høj koncentration af VEGF-receptorfusionsprotein |
| AU2019394227B2 (en) * | 2018-12-07 | 2023-04-06 | Remegen Co., Ltd. | Bifunctional angiogenesis inhibitor and use thereof |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| WO2021108530A1 (en) * | 2019-11-26 | 2021-06-03 | University Of Massachusetts | Recombinant adeno-associated virus for delivery of kh902 (conbercept) and uses thereof |
| SG11202110968VA (en) | 2019-12-06 | 2021-10-28 | Regeneron Pharma | Anti-vegf protein compositions and methods for producing the same |
| AU2021268026A1 (en) | 2020-05-08 | 2023-01-19 | Regeneron Pharmaceuticals, Inc. | VEGF traps and mini-traps and methods for treating ocular disorders and cancer |
| KR20240008821A (ko) | 2021-05-17 | 2024-01-19 | 리제너론 파아마슈티컬스, 인크. | 혈관신생성 눈 장애 치료를 위한 연장된 고용량 vegf 길항제 요법 |
| IL315347A (en) | 2022-03-15 | 2024-11-01 | Regeneron Pharma | Prolonged high-dose VEGF antagonist regimens for the treatment of angiogenic ocular disorders |
| IL315374A (en) | 2022-03-15 | 2024-11-01 | Regeneron Pharma | Prolonged high-dose VEGF antagonist regimens for the treatment of angiogenic ocular disorders |
| TW202412840A (zh) | 2022-09-16 | 2024-04-01 | 大陸商齊魯製藥有限公司 | 一種穩定的高濃度自緩衝藥物組合物 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| CN121712520A (zh) | 2023-06-23 | 2026-03-20 | 瑞泽恩制药公司 | 用于治疗血管生成性眼病的延长的高剂量vegf拮抗剂方案 |
| CN120204358A (zh) * | 2023-12-27 | 2025-06-27 | 成都康弘生物科技有限公司 | 一种含有抗vegf的融合蛋白的药物组合物 |
| WO2025217334A1 (en) | 2024-04-09 | 2025-10-16 | Regeneron Pharmaceuticals, Inc. | Low concentration vegf receptor fusion protein containing formulations |
| CN118108862B (zh) * | 2024-04-29 | 2024-08-09 | 上海鼎新基因科技有限公司 | 抗血管新生的融合蛋白及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| CN101433715B (zh) * | 1999-06-08 | 2013-04-17 | 里珍纳龙药品有限公司 | 具有改善的药物动力学特性的修饰嵌合多肽 |
| MXPA06003164A (es) * | 2003-09-23 | 2006-06-05 | Novartis Ag | Combinaciones de un inhibidor del receptor de vegf con otros agentes terapeuticos. |
| CN1304427C (zh) * | 2004-06-08 | 2007-03-14 | 成都康弘生物科技有限公司 | 抑制血管新生的融合蛋白质及其用途 |
| EP1767546B1 (en) * | 2004-06-08 | 2012-03-07 | Chengdu Kanghong Biotechnologies Co., Ltd. | Angiogenesis-inhibiting chimeric protein and the use |
-
2006
- 2006-03-31 CN CNB2006100662572A patent/CN100502945C/zh not_active Expired - Lifetime
-
2007
- 2007-03-29 KR KR1020087025464A patent/KR20090010030A/ko not_active Withdrawn
- 2007-03-29 WO PCT/CN2007/001021 patent/WO2007112675A1/zh not_active Ceased
- 2007-03-29 CA CA002647142A patent/CA2647142A1/en not_active Abandoned
- 2007-03-29 EP EP07720595A patent/EP2000483A4/en not_active Withdrawn
- 2007-03-29 RU RU2008136655/13A patent/RU2008136655A/ru not_active Application Discontinuation
- 2007-03-29 BR BRPI0710223-2A patent/BRPI0710223A2/pt not_active IP Right Cessation
- 2007-03-29 JP JP2009501824A patent/JP2009531036A/ja active Pending
- 2007-03-29 AU AU2007234272A patent/AU2007234272A1/en not_active Abandoned
-
2008
- 2008-09-29 US US12/241,017 patent/US20090264358A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009531036A5 (https=) | ||
| RU2008136655A (ru) | Гибридные белки рецептора vegf, их фармацевтические композиции и терапевтическое применение при заболеваниях глаз | |
| Starita et al. | Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy | |
| KR101884616B1 (ko) | 유착 치료 또는 예방용 폴리펩티드 | |
| Rockey | Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy | |
| NO336021B1 (no) | Anvendelse av en antagonist av Angptl3 til fremstilling av et medikament for behandling eller forebygging av vevsskade forbundet med en inflammatorisk leversykdom, og en antagonist av Angptl3 for nevnte anvendelse. | |
| WO2005121176A1 (en) | Angiogenesis-inhibiting chimeric protein and the use | |
| CN102020704A (zh) | 治疗胃肠病的方法和组合物 | |
| RU2012148887A (ru) | Варианты дезинтегрина и их фармацевтическое применение | |
| CN110087666B (zh) | 用于治疗糖尿病、高血压和高胆固醇血症的组合物和方法 | |
| JP2012505154A5 (https=) | ||
| KR20200078425A (ko) | 재조합 변형된 섬유아세포 성장 인자 및 이의 치료적 용도 | |
| US10709757B2 (en) | Pharmaceutical composition for anti-angiogenesis containing cyclic pentadepsipeptide as an effective ingredient | |
| JP2024003130A (ja) | 糖尿病性腎症の予防薬及び／又は治療薬 | |
| WO2010129284A1 (en) | Inhibition of hair follicle growth by the wnt inhibitor dkk1 | |
| CN114466859B (zh) | 一种用于血管新生、淋巴管新生相关疾病的多肽及其用途 | |
| JPWO2020009248A1 (ja) | 眼組織の線維化抑制用組成物 | |
| CN105218683B (zh) | 一种Tat PTD-Endostatin-RGD重组蛋白及其制备方法与应用 | |
| CN100484957C (zh) | 胸腺素β4衍生物及其应用 | |
| CN115057917B (zh) | 一种神经保护活性多肽及其应用 | |
| CN113846098B (zh) | 一种小rna及其在心血管疾病治疗中的用途 | |
| WO2012013110A1 (zh) | 具有抑制血管生成活性的多肽 | |
| CN110669143B (zh) | 一种短肽及其应用 | |
| CN116239701B (zh) | 一种融合蛋白及其应用 | |
| CN104288764A (zh) | Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用 |